UBS AG, London Branch Share Price

Certificat

DE000UBS19U1

Delayed Deutsche Boerse AG 11:02:09 01/07/2024 pm IST
691.8 EUR +1.03% Intraday chart for UBS AG, London Branch
1 month-1.26%
3 months+3.57%
Date Price Change
01/24/01 691.8 +1.03%
28/24/28 684.8 +0.46%
27/24/27 681.6 +0.81%
26/24/26 676.1 -2.35%
25/24/25 692.4 +0.47%

Delayed Quote Deutsche Boerse AG

Last update July 01, 2024 at 11:02 pm IST

More quotes

Static data

Product typeOther Certificates
Buy / SellCALL
Underlying PFIZER, INC.
Issuer UBS
WKN UBS19U
ISINDE000UBS19U1
Date issued 23/02/2022
Strike 36.4 $
Maturity 18/02/2027 (962 Days)
Parity 0.04 : 1
Emission price 1,010
Emission volume N/A
Settlement both
Currency EUR

Technical Indicators

Highest since issue 1,003
Lowest since issue 587.4
Spread 10
Spread %1.42%

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
27.98 USD
Average target price
31.92 USD
Spread / Average Target
+14.07%
Consensus